Data shown is for informational purposes only and does not constitute investment advice. TopFund is not SEBI-registered. Consult a SEBI-registered advisor before investing.
Fabtech Technologies IPO
Price Band
₹181.0–191.0
Issue Size
₹230.3 Cr
Lot Size
75 shares
Min Investment
₹14,325
GMP
—
Issue Price
₹191.0
Fabtech Technologies IPO AI Summary
- Fabtech Technologies IPO is listed on BSE, NSE in the Medical Equipment & Supplies sector.
- Price band: ₹181.0–₹191.0 per share, lot size 75 shares (min. investment ₹14,325).
- Subscription window: 29 Sep–01 Oct 2025, listing on 07 Oct 2025.
Fabtech Technologies Ltd, a biopharma engineering firm, is set to raise ₹230.3 Cr through its IPO, with a price band of ₹181.0 to ₹191.0. The company has shown consistent revenue and profit growth over the past three years, indicating a positive financial trajectory.
TopFund is not SEBI-registered — this is educational analysis, not personalized investment advice.
Fabtech Technologies IPO — Third-Party Research Views
Reviews below reflect analyst calls made before this IPO closed on 01 Oct 2025 — not a current signal.
2 of 2 reviewers say Neutral
Recommendations are sourced from third-party research firms and are not TopFund's own investment advice.
Important Dates
Subscription Status
Subscription data unavailable
Fabtech Technologies IPO Grey Market Premium (GMP) Today
GMP not available yet
Grey Market Premium is updated daily. Check back closer to the listing date.
About the Company
Incorporated in 2018, Fabtech Technologies Ltd is a biopharma engineering company. The company designs and delivers turnkey projects, including cleanroom facilities, modular systems, and customised engineering solutions. It provides end-to-end services such as design, engineering, manufacturing, installation, and project management. With expertise in cleanroom technology, HVAC systems, and process equipment, Fabtech serves global clients, ensuring compliance with international regulatory standards. Services: Start-to-Finish: The company helps people in the bio-pharma manufacturing life cycle from setting direction right through to taking your products to market. Clean Water Solutions: The company offers a comprehensive range of equipment for purified water and pure steam generation and distribution, as well as water for injections with flow rates ranging from 500 LPH to 50,000 LPH.. Clean Air Solutions: The company supported life sciences, food and beverage, IT, semiconductor, and aeronautics industries with innovative solutions for clean air applications that drive their growth and progress. As of July 31, 2025, the company had 185 permanent employees. Competitive Strengths: A key turnkey engineering solution provider offering integrated engineering solutions with comprehensive service offerings. In-house software technology capabilities Diversified order book across geographies, clients, and business verticals. Project execution across diverse and challenging geographies Efficient lead funnelling leading to higher mandate conversion Track record of executing projects across all dosage forms Experienced Leadership Team with Fabtech Group parentage
Company Financials (₹ Cr)
As of 2025-03-31
| Period Ended | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|
| Assets | 426.56 | 269.24 | 213.86 |
| Total Income | 335.94 | 230.60 | 199.91 |
| Profit After Tax | 46.33 | 27.22 | 21.58 |
| EBITDA | 47.28 | 39.75 | 32.38 |
| NET Worth | 173.11 | 131.88 | 88.96 |
| Reserves and Surplus | 140.72 | 128.94 | 86.18 |
| Total Borrowing | 54.62 | 9.88 | 34.29 |
Key Ratios
EPS
₹14.34
NAV
₹53.44
ROE
30.46%
ROCE
24.46%
RoNW
26.83%
P/B Value
3.57
P/E Ratio
13.32
Market Cap
₹849.04 Cr
PAT Margin
13.83%
Debt/Equity
0.32
Promoters
Aasif Ahsan Khan, Hemant Mohan Anavkar, Aarif Ahsan Khan and Manisha Hemant Anavkar
Objects of the Issue
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects: # Issue Objects Est Amt (₹ Cr.) 1 Funding working capital requirements of the Company 127.00 2 Pursuing inorganic growth initiatives through acquisitions 30.00 3 General Corporate Purposes 50.52 4 Issue Expenses 22.78 Total 230.30
IPO Evaluation
Generated 23 Sep 2026Revenue Trend
Total Income was ₹199.91 Cr in the year ending 31 Mar 2023, increasing to ₹230.60 Cr by 31 Mar 2024, and further rising to ₹335.94 Cr by 31 Mar 2025. This indicates a consistent growth in revenue over the periods.
Profit Trend
Profit After Tax was ₹21.58 Cr for the year ending 31 Mar 2023, which increased to ₹27.22 Cr by 31 Mar 2024, and further rose to ₹46.33 Cr by 31 Mar 2025. This shows a positive trend in profitability across the reported periods.
Grey Market Premium, Explained
The Grey Market Premium (GMP) refers to the unofficial trading of shares before they are listed on the stock exchange. It indicates the expected listing price of the IPO based on demand in the grey market. A positive GMP suggests strong demand, while a negative GMP may indicate weak interest.
Who This IPO Suits
Investors comfortable with short-term volatility and a long-term horizon typically weigh IPOs like this against the company's growth potential, industry position, and financial performance. It is important to consider how the company's business model aligns with market trends and regulatory environments.
Who May Want to Wait
Investors who are risk-averse or prefer stable returns may want to avoid IPOs like this, especially if they are not comfortable with the inherent uncertainties and potential fluctuations in the stock price following the listing.
IPO Timeline, Explained
The IPO process includes several key dates: the opening date for subscription is on 29 Sep 2025, closing on 01 Oct 2025, with allotment expected on 03 Oct 2025 and listing on the stock exchange on 07 Oct 2025.
Listing Gains — The Risk
Listing gains refer to the potential profit an investor can make when shares are sold on the listing day at a price higher than the issue price. However, these gains are not guaranteed and can be influenced by market conditions, investor sentiment, and overall demand for the stock.
This evaluation is generated from Fabtech Technologies's own public IPO filing data for educational purposes and is not investment advice or a recommendation to apply, subscribe to, or avoid this issue — see Broker Recommendations below for named third-party research views (clearly attributed, not TopFund's own). TopFund is not a SEBI-registered investment adviser — see our Disclaimer.
Frequently Asked Questions
What is the price band of Fabtech Technologies IPO?
The price band of Fabtech Technologies IPO is ₹181.0–₹191.0 per share.
When does Fabtech Technologies IPO open and close?
Fabtech Technologies IPO opens on 29 September 2025 and closes on 01 October 2025.
When does Fabtech Technologies IPO list on the stock exchange?
Fabtech Technologies IPO listed on 07 October 2025 at ₹191.0.
What is the lot size for Fabtech Technologies IPO?
The lot size for Fabtech Technologies IPO is 75 shares, requiring a minimum investment of ₹14,325.
What is the price band for the IPO?
The price band for the IPO is ₹181.0 to ₹191.0.
What is the minimum investment required?
The minimum investment required is ₹14,325.0.
What is the lot size for the IPO?
The lot size for the IPO is 75 shares.
When is the IPO expected to be listed?
The IPO is expected to be listed on 07 Oct 2025.
What does GMP mean?
GMP stands for Grey Market Premium, which indicates the expected listing price of the IPO based on demand in the unofficial market.
Issue Details
Investor Allocation
Registrar
Lead Managers / Book Running
IPO Timeline
Open
29 Sep 2025
Close
01 Oct 2025
Allotment
03 Oct 2025
Listing
07 Oct 2025
Similar IPOs in Medical Equipment & Supplies
Plan Your IPO Investment
Related Articles
Community Sentiment
What are other investors planning for Fabtech Technologies?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
No comments yet — start the discussion.